
New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21 Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR⍺)-targeting antibody-drug conjugate (ADC) New ADC candidates, including Z…
Title: Design and evaluation of mRNA translation inhibitors for use as antibody drug conjugate payloadsAbstract: 2062Session: ChemistryDate/Time: Monday, April 20, 2026 at 9:00 am 12:00 pm PST
A nov… [+7296 chars]









